ICMR Director General Dr. Rajiv Bahl clarified that the current H1N1 surge in India represents seasonal flu rather than a new strain. Nationwide surveillance across 73 labs shows Influenza A and B circulating alongside declining COVID-19 cases

Dr Swaminathan said the present rise in cases is linked to the H1N1 Michigan strain, which has been circulating since the 2009 pandemic, and not due to the emergence of any new variant.

As H1N1 cases rise in Delhi and Bengaluru, a look back at the 2009 swine flu pandemic shows how the world detected, tracked, treated and vaccinated against a new influenza virus, and what India learned...

With H1N1 cases rising in Delhi-NCR and influenza increasing in Bengaluru, doctors say vaccination can reduce the risk of severe flu. Here's who should prioritise the annual flu shot, when to get it and what to know about safety

For the first time, the Census will collect caste details, alongside questions on bank accounts, Aadhaar and passport numbers.

Hepatitis is often silent but should never be ignored. If you have a family history of hepatitis B, have undergone blood transfusions in the past, received tattoos or piercings in unsafe settings, or have any other risk factors

The development comes as India continues to carry one of the world's highest cervical cancer burdens. According to the World Health Organisation, cervical cancer remains the second most common cancer among Indian women after breast cancer.

India's investigational HPV pill, SHetA2, has sparked hope in the fight against cervical cancer. But experts caution it's still years away from patients

India has taken a significant step towards preventing cervical cancer with SHetA2, a first-in-class anti-HPV drug candidate licensed by the Indian Council of Medical Research (ICMR) to Emcure Pharmaceuticals

Dr Sowrabh Kumar Arora and Dr Malay Nandy explain why head and neck cancer is on the rise. They also explains why early screening and vaccination are essential.

The initiative follows India's supply of over 45 tonnes of medical assistance to the Africa Centres for Disease Control and Prevention in May and June.

The approval of India's first dengue vaccine marks a genuine milestone. But the real question facing policymakers concerns whether the health system is prepared to use it well

The vaccine, approved by the Central Drugs Standard Control Organisation (CDSCO), is the first dengue vaccine cleared for use in India. Developed by Japanese pharmaceutical company Takeda, QDENGA is designed to protect against all four dengue virus types.

Three persons infected with Coronavirus have been admitted to a private hospital in Kolkata. Earlier, a 10-year-old boy had to be admitted to a private hospital in Kolkata after being infected with Coronavirus.

Experts say that along with Covid-19, there is also a rise in influenza, adenoviruses, and rhinoviruses, which has led to a growing number of patients visiting hospitals with cough, fever, sore throat, and body aches.

India has approved Takeda's QDENGA, its first dengue vaccine. Here's how it works, who can receive it, its effectiveness, likely price, rollout plans, and what it means for dengue prevention in one of the world's most affected countries.

Serum Institute partners with Gates MRI to manufacture experimental TB vaccine M72/AS01E, aiming to be first new TB vaccine in over a century.

Doctors say older adults, pregnant women, and people with diabetes, heart disease, chronic lung disease, kidney disease, cancer, or weakened immunity remain more vulnerable to severe illness.

The Department of Health Research has unveiled the Draft National Health Research Policy 2026, it marks the India's first comprehensive framework designed to unify health research across all sectors

Jaan Kumar Sanu's Covid-19 diagnosis is a reminder that the virus has not disappeared. However, thanks to vaccination and widespread immunity, most infections today are mild and recover with supportive care at home.

The Phase I clinical trial will take place in Oxford and involve 50 healthy volunteers between the ages of 18 and 55. The goal of this first-stage study is to check whether the vaccine is safe and whether it triggers the body's immune system to produce protection against the virus.

The government has steadily expanded the use of QR codes to make fake medicines harder to introduce into the supply chain.

India was officially declared polio-free on 27 March 2014. However, mass immunisation remains vital to sustain India's polio-free status.

Health authorities have completed the deployment of vaccines, logistics, trained vaccination teams and supervisors at all designated locations to facilitate the statewide immunisation exercise.